M. Llansola et al., Inhibitors of phospholipase C prevent glutamate neurotoxicity in primary cultures of cerebellar neurons, J PHARM EXP, 292(3), 2000, pp. 870-876
Citations number
34
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The role of phospholipase C in the molecular mechanism of glutamate neuroto
xicity was assessed in primary cultures of cerebellar neurons. It is shown
that 1-[6-[[(17b)-3-methoxyestra- 1,3,5(10)-trien-17-yl]amino] hexyl]-1H-py
rrole-2,5-dione (U-73122) and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosph
orylcholine (Et-18-OCH3), two agents that inhibit phospholipase C, prevent
glutamate and N-methyl-D-aspartic acid (NMDA) neurotoxicity. It is shown th
at both compounds prevent glutamate neurotoxicity at concentrations lower t
han those required to inhibit carbachol-induced hydrolysis of inositol phos
pholipids. In contrast, it was a good correlation between the concentration
s of U-73122 and Et-18-OCH3 required to inhibit NMDA-induced hydrolysis of
phospholipids and those required to prevent glutamate and NMDA neurotoxicit
y. NMDA-induced hydrolysis of phospholipids is inhibited by nitroarginine,
an inhibitor of nitric-oxide synthase, and is mimicked by the nitric oxide-
generating agent S-nitroso-N-acetylpenicillamine. The results reported indi
cate that glutamate neurotoxicity would be mediated by activation of NMDA r
eceptors, leading to activation of nitric-oxide synthase and increased form
ation of nitric oxide, which results in increased activity of phospholipase
C. Inhibition of phospholipase C by U-73122 or Et-18-OCH3 prevents glutama
te-induced neuronal death.